New research aims to determine reliability of blood samples taken by PH patients at home for remote monitoring

New research at Royal Brompton and Harefield hospitals in the U.K. will evaluate whether the levels of NT-proBNP, a heart damage biomarker that serves as a prognostic marker of pulmonary hypertension, can be accurately measured in a finger-prick blood sample that can be taken by patients at home and sent by mail to laboratories (this is usually measured using blood taken from the arm, known as a venous blood sample). The study is important in order to establish the reliability of the NT-proBNP blood samples in remote monitoring. The project is funded by Janssen Pharmaceuticals.

Source: Article in Pulmonary Hypertension News by Marta Figueiredo PhD, January 28, 2022

Official press release at this link

Photo credit Unsplash